Honz Pharmaceutical Co., Ltd. (SHE:300086)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sales of Daily Necessities	39.74M	-	-	80.58M	99.45M
Production and Sales of Daily Necessities Growth	-	-	-	-18.97%	-9.73%
Pharmaceutical Manufacturing and Sales Division	431.30M	-	-	455.16M	573.81M
Pharmaceutical Manufacturing and Sales Division Growth	-	-	-	-20.68%	4.90%
Inter-Segment Elimination	-4.91M	-	-	-	-
Medical Services Division	-	-	-	-	163.31M
Medical Services Division Growth	-	-	-	-	-38.25%
Total	466.12M	-	-	535.75M	836.57M
Total Growth	-	-	-	-35.96%	-9.23%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2025	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	464.49M	467.78M	738.44M	535.55M	835.94M
China Growth	-0.70%	-36.65%	37.88%	-35.93%	-8.96%
Foreign	1.63M	1.74M	1.13M	190.87K	628.05K
Foreign Growth	-6.42%	54.28%	491.85%	-69.61%	-81.70%
Total	466.12M	469.53M	739.57M	535.75M	836.57M
Total Growth	-0.72%	-36.51%	38.05%	-35.96%	-9.23%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error